Category: About ARMA

Lupus UK Strategy insight surveys and focus groups

Lupus UK are conducting surveys and focus groups to develop their aims and priorities for the next 5 years. They want to hear from the whole lupus community about what you want and need, including people living with lupus and those who support them personally or professionally. Your voice matters, and Lupus UK is are listening.

…

Read more of this article

Arthritis Action Impact Report 2023-24

Arthritis Action is pleased to share their Impact Report 2023-24, capturing their key achievements over the course of that year. Reaching more people than ever, the charity held over 120 group meetings, events and presentations with more than 9,000 people in attendance. Arthritis Action supported over 200,000 people through their website, raised awareness and reached over 2 million on social media, with a combined publicity and PR reach of 152 million.

You can read the full report here on the website [PDF].

NRAS 3-Year Strategy survey

The National Rheumatoid Arthritis Society (NRAS) is gearing up to launch its groundbreaking three-year strategy in 2025. To make sure this strategy truly reflects the needs and aspirations of those it serves, NRAS teamed up with TwoCan Associates to conduct an insightful survey.

By gathering the invaluable perspectives of people living with RA and JIA, as well as health professionals, NRAS is ensuring that its future initiatives will be impactful, inclusive, and driven by real-world experiences.

You can see the full report here.

ARMA responds to NHS 10-Year Plan Consultation

ARMA has submitted a response to the Government’s consultation on the NHS 10-Year Plan.

The submission was produced with ARMA members who gave their views in a series of meetings. The response calls for MSK conditions to have the long-overdue acknowledgment and equal footing alongside other long-term conditions and highlights the substantial impact that MSK conditions have on individuals’ lives, the NHS and the wider economy.

You can read ARMA’s submission here.

ORUK publishes annual Impact Report

stock imageThe latest Orthopaedic Research (ORUK) Impact Report highlights how the charity continues to make a difference by focusing its investments, partnering with others and supporting the wider MSK research ecosystem through training, events and networking. It continues to be one of the most important funders of MSK research in the UK and the only charity to cover all MSK conditions.

ORUK co-funded research projects worth over £2m in 2023/24. This research funding was allocated to diagnosis, treatment, management and prevention, and a wide range of MSK conditions affecting all body parts including cell bone and soft tissue biology, biomechanics and prosthetics, osteoarthritis, bone fractures, spinal conditions, trauma, bone cancer, rehabilitation and fibromyalgia.…

Read more of this article

ARMA welcomes new Chair

Following elections at the recent AGM, ARMA welcomed a new Chair of our board of trustees.

Speaking about his new role, ARMA Chair Chris Martey said: “I am delighted to be stepping into the role of Chair in this pivotal time for the charity, where it’s work, reach and impact is going from strength to strength. It is a privilege to be taking over the mantle from Dirk, having worked closely alongside him as Vice-Chair during the last year of his tenure.…

Read more of this article

UCO joins Health Sciences University

The University College of Osteopathy (UCO) has officially joined Health Sciences University (HSU), formerly known as AECC University College, as of 1 August 2024.

The UCO School of Osteopathy, now part of HSU, continues its rich heritage of over 100 years of osteopathic education and research excellence. This significant transition honours UCO’s legacy and opens up new opportunities for collaboration and growth into the broader health sciences sector. For more information, visit here.

Opportunity to host a SOMM course in 2025

The Society of Musculoskeletal Medicine will have a busy few months ahead with their ‘Foundation in Musculoskeletal Medicine’ and ‘Theory and Practice of Injection Therapy’ courses; webinars; and hosting collaborative events.

SOMM is also planning their 2025 programme. If someone would like to host a SOMM course next year, please email SOMM’s office for more information: admin@sommcourses.org

 

New CEO takes up post at NRAS

Peter FoxtonThe National Rheumatoid Arthritis Society (NRAS) is delighted to announce the arrival of its new CEO, Peter Foxton. Peter takes over from Clare Jacklin who steps down after 5 years as Chief Executive and over 17 years working with the charity.

Peter arrives with a background in fundraising and retail, and for the last 14 years has been working at Phyllis Tuckwell Hospice in Surrey as Director of Income Generation. Prior to that, Peter worked in both the commercial and charity retail sectors.…

Read more of this article

ARMA Announces New Trustee

Noha Al AfifiARMA is delighted to welcome our newest Trustee Noha Al Afifi, interim CEO of Arthritis Action. We look forward to working closely with Noha and know the wealth of experience she brings to ARMA will be an asset to the organisation.

Speaking about her election Noha stated: “I am proud and pleased to be joining the Arthritis & Musculoskeletal Alliance Board and look forward to working with them as a Trustee, raising the awareness of the impact MSK conditions have on all members of society and how we can tackle health inequalities.”